FindTrial
Sign In

Effect of Products on skin ageing

To evaluate & compare the in-vivo safety and efficacy of a skin care formulation versus placebo in terms of reduction in fine lines and wrinkles, reduction in dark spots, skin firmness, skin brightness, skin water barrier function and skin moisturization on healthy human subjects - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/072188
Enrollment
36
Registered
2024-08-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Anti-ageing cream with Kopuchiol: Product is applied on the whole face, once in a day for the period of 84 days Control Intervention1: Placebo: Product is applied on the whole face, onc

Sponsors

KOP research centre private limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Indian female subjects 2.Healthy subjects 3.Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar….) 4.Subject having Crows feet wrinkle 5.Subject having dark spots

Exclusion criteria

Exclusion criteria: 1. Being pregnant or breastfeeding or having stopped to breastfeed in the past three months 2. Having refused to give her/his assent by not signing the consent form 3. Taking part in another study liable to interfere with this study 4. Being insulin-dependent diabetic or non-insulin-dependent diabetic with a recent therapy (less than 6 months) 5. Having a progressive asthma (either under treatment or last fit in the last 2 years) 6. Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area (except for specific studies on a determined dermatosis) 7. Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months) 8. Being epileptic. 9. Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol) 10. Having cutaneous hypersensitivity. 11. Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products. 12. Having undergone a surgery requiring a general anesthetic of more than one hour in the past 6 months.

Design outcomes

Primary

MeasureTime frame
Reduction in fine lines and wrinkles, reduction in dark spots (age spots), skin firmness, skin brightness, skin water barrier function and skin moisturizationTimepoint: Baseline, Day14, Day28, Day56, day84—

Secondary

MeasureTime frame
NilTimepoint: NA—

Countries

India

Contacts

Public ContactDr Mohit Lalvani

MASCOT-SPINCONTROL India Pvt. Ltd.

poojayadav@mascotspincontrol.in02243349191

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026